- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Low vitamin D levels, high BMI and blood sugar tied to severity of COVID-19: Study
Italy: A recent study for the first time showed a strict association of Vitamin D levels with blood sugar and BMI in COVID-19 patients. The study, published in The Journal of Clinical Endocrinology and Metabolism, is a substudy of a prospective observational study performed at a hospital in Italy.
According to the study, vitamin D deficiency might be a novel mechanism involved in the detrimental effect of adiposity and hyperglycemia on disease severity.
Previous studies have shown a high prevalence of vitamin D deficiency in COVID-19 patients and hypothesized to increase COVID-19 severity likely due to its negative impact on inflammatory and immune responses. Also, clear associations between hypovitaminosis-D and fat body-mass excess and diabetes, factors associated with COVID-19 severity, have been widely recognized.
Against the above background, Andrea Giustina, IRCCS San Raffaele Hospital, Milan, Italy, and colleagues aimed to evaluate the relationship between VD levels and inflammatory response, BMI, blood glucose, and disease severity in COVID-19 patients.
The study enrolled patients admitted to San Raffaele-Hospital for COVID-19. Those with comorbidities and therapies influencing VD-metabolism were excluded. 25(OH)VD levels, plasma glucose levels, BMI, and inflammatory parameters were evaluated at admission.
A total of 88 patients were included.
Based on the study, the researchers found the following:
- Median VD level was 16.3 ng/mL and VD-deficiency was found in 68.2% of patients.
- VD-deficiency was found more frequently in male patients and in those affected by severe COVID-19.
- Regression analyses showed a positive correlation between VD and PaO2/FiO2 ratio, and negative correlations between VD and plasma glucose, BMI, Neutrophil/Lymphocyte ratio, CRP and IL-6.
- Patients with both hypovitaminosis-D and diabetes mellitus, as well those with hypovitaminosis-D and overweight, were more frequently affected by a severe disease with worse inflammatory response and respiratory parameters, compared to those without or just one of these conditions.
"Our findings, for the first time, showed a strict association of Vitamin D levels with blood glucose and BMI in COVID-19 patients," wrote the authors. " Vitamin D-deficiency might be a novel common pathophysiological mechanism involved in the detrimental effect of hyperglycemia and adiposity on disease severity."
Reference:
The study titled, "Vitamin D levels associate with blood glucose and BMI in COVID-19 patients predicting disease severity," is published in the Journal of Clinical Endocrinology and Metabolism.
DOI: https://academic.oup.com/jcem/advance-article/doi/10.1210/clinem/dgab599/6349205
MSc. Biotechnology
Medha Baranwal joined Medical Dialogues as an Editor in 2018 for Speciality Medical Dialogues. She covers several medical specialties including Cardiac Sciences, Dentistry, Diabetes and Endo, Diagnostics, ENT, Gastroenterology, Neurosciences, and Radiology. She has completed her Bachelors in Biomedical Sciences from DU and then pursued Masters in Biotechnology from Amity University. She has a working experience of 5 years in the field of medical research writing, scientific writing, content writing, and content management. She can be contacted at  editorial@medicaldialogues.in. Contact no. 011-43720751
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751